Literature DB >> 22538042

Colonic perforation induced by short term use of slow release diclofenac.

Noman Shahzad1, Asif Maqbool, Tooba Mahmud Gauhar, Khwaja Muhammad Azim.   

Abstract

Upper gastrointestinal (GI) toxicity of non-steroidal anti-inflammatory drugs (NSAIDs) is well characterized. There is also documented data regarding their adverse effects on lower GI tract, like colonic strictures, inflammatory bowel disease and complications of diverticular disease in the form of abscess or perforation. But there are only two case reports published previously that show colonic perforation due to use of NSAIDs solely. We present here a case of colonic perforation induced by short-term use of slow release diclofenac in a young man. Colonic perforation should be considered as the possible diagnosis in patients with acute abdomen and NSAIDs to be one of the differentials if other possibilities are ruled out.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22538042     DOI: 05.2012/JCPSP.328329

Source DB:  PubMed          Journal:  J Coll Physicians Surg Pak        ISSN: 1022-386X            Impact factor:   0.711


  4 in total

1.  Lower gastrointestinal adverse effects of NSAIDS: an extreme example of a common problem.

Authors:  Ramin Mandegaran; Ciáran Conway; Colin Elton
Journal:  BMJ Case Rep       Date:  2013-02-20

Review 2.  Medical influences, surgical outcomes: role of common medications on the risk of perforation from untreated diverticular disease.

Authors:  Gianpiero Gravante; Shuker Yahia
Journal:  World J Gastroenterol       Date:  2013-09-28       Impact factor: 5.742

3.  Perforated diverticulitis sigmoidei after laparoscopic cholecystectomy.

Authors:  Salameh Eljaja; Sabah Hadi; Alaa El-Hussuna
Journal:  J Surg Case Rep       Date:  2015-03-13

4.  The Preventive and Therapeutic Effects of Ajwa Date Fruit Extract Against Acute Diclofenac Toxicity-Induced Colopathy: An Experimental Study.

Authors:  Shaimaa Mohamed Abdelfattah Hassan; Moutasem Salih Aboonq; Emad A Albadawi; Yasmeen Aljehani; Hytham Mahmoud Abdel-Latif; Reham A Mariah; Noha M Shafik; Tamer M Soliman; Abdelhady Ragab Abdel-Gawad; Faten M Omran; Wafaa A Abdellah; Ahmed Shehata; Husam Shahada; Hussam H Baghdadi; Hanan Yousef Aly; Alfarazdeg Saad; Manal Mohamed Helmy Nabo; Abdullah Almilaibary; Heba M Eltahir; Salah Mohamed El Sayed; Mustafa A M Abu-Elnaga; Yasser M Elbastawisy
Journal:  Drug Des Devel Ther       Date:  2022-08-06       Impact factor: 4.319

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.